Transient Improvement after Switch to Low Doses of RimabotulinumtoxinB in Patients Resistant to AbobotulinumtoxinA

Botulinum toxin type B (BoNT/B) has been recommended as an alternative for patients who have become resistant to botulinum toxin type A (BoNT/A). This study aimed to compare the clinical effect, within a patient, of four injections with low doses of rimabotulinumtoxinB with the effect of the precedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefter, Harald, Samadzadeh, Sara, Moll, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693617/
https://www.ncbi.nlm.nih.gov/pubmed/33121133
http://dx.doi.org/10.3390/toxins12110677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693617/
https://www.ncbi.nlm.nih.gov/pubmed/33121133
http://dx.doi.org/10.3390/toxins12110677

Ejemplares similares